SOLID ORAL DOSAGE FORMS OF VALSARTAN Russian patent published in 2012 - IPC A61K9/20 A61K31/41 A61P9/12 A61K31/549 

Abstract RU 2453306 C2

FIELD: medicine.

SUBSTANCE: present invention refers to medicine and describes a method for preparing a tablet exhibiting antihypertensive activity containing a) an active substance containing valsartan 80 or 160 mg or its pharmaceutically acceptable salt, and hydrochlorothiazide (HCTZ) 12.5 or 25 mg; b) pharmaceutical acceptable additives suitable for preparing tablets by compression wherein said method involves the stages, I) grinding of the active substance which contains said valsartan and said hydrochlorothiazide, and pharmaceutically acceptable additives; II) compression of a mixture of the grinded active substance and additives with making a comprimate with said compression for making the comprimate requires compaction of the dry mixture of the grinded ingredients; III) transformation of the comprimate into a granulate having a particle size distribution 9 to 340 micron; and IV) compression of the granulate with preparing the tablet.

EFFECT: method provides preparing the tablet possessing intensified antihypertensive activity.

4 cl, 3 ex

Similar patents RU2453306C2

Title Year Author Number
VALSARTAN-BASE SOLID ORAL DOSING FORMULATIONS 1997
  • Vagner Robert Frehnk
  • Katakuse Joshimitsu
  • Tajke Takashi
  • Jamato Fudziki
  • Kol'Mejer Manfred
RU2294743C2
SOLID ORAL DOSED VALSARTAN-BASED FORMS 1997
  • Vagner Robert Frehnk
  • Katakuse Joshimitsu
  • Tajke Takashi
  • Jamato Fudziki
  • Kol'Mejer Manfred
RU2203054C2
PHARMACEUTICAL COMPOSITIONS 2001
  • Ganter Zabina Marija
  • Vagner Robert Frehnk
RU2333757C2
GALENA COMPOSITION OF ALISKIREN AND HYDROCHLOROTHIAZIDE 2007
  • Vill'Mann Mattias
RU2491058C2
SOLID PERORAL DOSED OUT FORMS OF VALSARTAN 2005
  • Ballok Dzhillian Rouzmari
  • De-Gasparo Mark
  • Ganter Zabine Marija
RU2361575C2
DIPHOSPHONIC ACID-CONTAINING COMPOSITIONS 1999
  • Gabel' Rol'F-Diter
  • Prajz Val'Ter
  • Voog Genrikh
RU2207860C2
USING RECEPTOR AT-1 ANTAGONIST OR RECEPTOR AT-2 MODULATOR IN TREATMENT OF DISEASES ASSOCIATED WITH INCREASE CONTENT OF AT-1 OR AT-2 RECEPTORS 1999
  • Ballok Dzhillian Rouzmari
  • De-Gasparo Mark
  • Ganter Zabina Marija
RU2271809C2
PHARMACEUTICAL COMPOSITION OF DIURETIC, DEHYDRATING AND HYPOTENSIVE ACTION 2002
  • Nesteruk V.V.
  • Syrov K.K.
RU2201753C1
SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD FOR MAKING THEM 2007
  • Kao Ju
  • Dzhoshi Jatindra
  • Li Pin
  • Pudipeddi Madkhusudkhan
  • Rous Alan Ehduard
  • Uogner Robert Frank
  • Chzhu Tszjakhao
RU2449786C2
CEFUROXIMAXETIL-CONTAINING COMBINATIONS 1999
  • Khervig Jennevajn
  • Iogannes Raneburger
RU2248794C2

RU 2 453 306 C2

Authors

Vagner Robert Frehnk

Katakuse Joshimitsu

Tajke Takashi

Jamato Fudzike

Kol'Mejer Manfred

Dates

2012-06-20Published

2007-01-10Filed